| Date | Title | Description | Source |
| 12.03.2024 | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial ... | ROCKVILLE, Md., March 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leadi... | einpresswi... |
| 04.03.2024 | MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023... | ROCKVILLE, Md., March 04, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leadi... | einpresswi... |
| 09.08.2023 | MaxCyte Reports Second Quarter and Half-Year 2023 Financial ... | ROCKVILLE, Md., Aug. 09, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leadin... | einpresswi... |
| 28.09.2022 | MaxCyte Signs Strategic Platform License with Vertex Pharmac... | Vertex Pharmaceuticals will continue to use MaxCyte’s Flow Electroporation® technology and ExPERT™ p... | globenewsw... |
| 07.09.2022 | MaxCyte to Participate in Morgan Stanley 20th Annual Global ... | ROCKVILLE, Md., Sept. 07, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leadi... | globenewsw... |
| 10.08.2022 | MaxCyte Reports Second Quarter and Half-Year 2022 Financial ... | 45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022
Raises 2022 Core Revenue Grow... | globenewsw... |
| 15.07.2022 | MaxCyte to Report Second Quarter 2022 Financial Results on A... | GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a lea... | globenewsw... |
| 12.07.2022 | MaxCyte Signs Strategic Platform License with LG Chem to Adv... | GAITHERSBURG, Md., July 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a lea... | globenewsw... |
| 13.05.2022 | MaxCyte Announces Inducement Grants Under Nasdaq Listing Rul... | GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a lead... | globenewsw... |
| 09.05.2022 | MaxCyte Reports First Quarter Financial Results | GAITHERSBURG, Md., May 09, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a lead... | globenewsw... |
| 03.05.2022 | MaxCyte to Participate in Upcoming Investor Conferences | GAITHERSBURG, Md., May 03, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a lead... | globenewsw... |
| 15.04.2022 | MaxCyte Announces Inducement Grants Under Nasdaq Listing Rul... | GAITHERSBURG, Md., April 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN)... | globenewsw... |
| 12.04.2022 | MaxCyte Announces Departure of CFO and Appointment of Ron Ho... | GAITHERSBURG, Md., April 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a le... | globenewsw... |
| 22.03.2022 | MaxCyte Reports Fourth Quarter and Full Year Financial Resul... | GAITHERSBURG, Md., March 22, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT) is a ... | globenewsw... |
| 09.03.2022 | MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer | GAITHERSBURG, Md., March 09, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT, MXCN)... | globenewsw... |
| 24.02.2022 | MaxCyte to Report Fourth Quarter and Full Year 2021 Financia... | GAITHERSBURG, M.D., Feb. 24, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN)... | globenewsw... |
| 12.02.2022 | MaxCyte Announces Inducement Grants Under Nasdaq Listing Rul... | GAITHERSBURG, Md., Feb. 11, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | marketscre... |
| 11.02.2022 | MaxCyte Announces Inducement Grants Under Nasdaq Listing Rul... | GAITHERSBURG, Md., Feb. 11, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | globenewsw... |
| 01.02.2022 | MaxCyte Signs Strategic Platform License with Intima Bioscie... | NEW YORK and GAITHERSBURG, Md., Jan. 31, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE:... | globenewsw... |
| 24.01.2022 | MaxCyte Announces Strong Preliminary Unaudited Fourth Quarte... | Fourth quarter 2021 revenue expected to be greater than $10 million
Full year 2021 revenue expected ... | globenewsw... |
| 12.11.2021 | MaxCyte to Participate in Upcoming Investor Conferences | GAITHERSBURG, Md., Nov. 12, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | globenewsw... |
| 11.11.2021 | MaxCyte Reports Third Quarter Financial Results | GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | marketscre... |
| 10.11.2021 | MaxCyte Reports Third Quarter Financial Results | GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | globenewsw... |
| 03.11.2021 | MaxCyte Board Member Richard Douglas, PhD, Appointed Chairma... | GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT, MXCN) ... | globenewsw... |
| 29.10.2021 | Result of AGM | GAITHERSBURG, Md., Oct. 29, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | globenewsw... |
| 28.10.2021 | MaxCyte Signs Strategic Platform License with Nkarta, Inc. t... | SOUTH SAN FRANCISCO and GAITHERSBURG, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq:... | globenewsw... |
| 28.10.2021 | MaxCyte Signs Strategic Platform License with Nkarta, Inc. t... | Nkarta to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to accelerate the deve... | marketscre... |
| 25.10.2021 | MaxCyte to Report Third Quarter 2021 Financial Results on No... | GAITHERSBURG, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN),... | globenewsw... |
| 20.04.2021 | MaxCyte : 2020 Full Year Results | MaxCyte, Inc.
('MaxCyte' or the 'Company')
MaxCyte Reports Final Results for the Year Ended 31 Decem... | marketscre... |
| 09.11.2020 | CARMA Cell Therapies™ to Share Results of In-vitro Character... | | prnewswire... |
| 18.08.2020 | CARMA Cell Therapies™ Expands Phase I Trial of Anti-Mesothel... | | prnewswire... |
| 17.09.2018 | Here’s a look at Maryland’s publicly-traded biotech companie... | When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government i... | technical.... |
| 26.05.2017 | Here’s who won TEDCO’s 2017 ICE awards | TEDCO’s ICE awards returned to Columbus Center in Inner Harbor on Thursday night.
The Maryland agenc... | technical.... |
| 13.01.2017 | HGP – MaxCyte Announces Strategic Immuno-Oncology Collaborat... | – Preclinical research to focus on developing therapies based on MaxCyte’s proprietary CARMA platfor... | harbert.ne... |
| 13.01.2017 | HGP – MaxCyte, NIH NIAID Study Published in Science Translat... | Gaithersburg, MD, January 12, 2017 – MaxCyte®, Inc., a developer and supplier of cell engineering pr... | harbert.ne... |
| 15.09.2015 | HVP – MaxCyte Appoints Chayon Laboratories as Distributor in... | Gaithersburg, MD, September 15, 2015 – MaxCyte®, Inc., the pioneer in scalable, high-performance cel... | harbert.ne... |
